Reviews Iressa


No reviews yet.

Iressa Drug Description
IRESSA®
(gefitinib) Tablets, 250 mg
DRUG DESCRIPTION



What are the possible side effects of gefitinib (Iressa)?

If you experience any of the following serious side effects from gefitinib, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
eye pain or irritation.

Other, less serious...
Read All Potential Side Effects for Iressa »




IRESSA® (gefitinib tablets) contain 250 mg of gefitinib and
are available as brown film-coated tablets for daily oral administration.
Gefitinib is an anilinoquinazoline with the chemical name 4-Quinazolinamine,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin) propoxy] and
the following structural formula:








It has the molecular formula C22H24ClFN4O3,
a relative molecular mass of 446.9 and is a white-colored powder. Gefitinib
is a free base. The molecule has pKas of 5.4 and 7.2 and therefore
ionizes progressively in solution as the pH falls. Gefitinib can be defined
as sparingly soluble at pH 1, but is practically insoluble above pH 7, with
the solubility dropping sharply between pH 4 and pH 6. In non-aqueous solvents,
gefitinib is freely soluble in glacial acetic acid and dimethylsulphoxide, soluble
in pyridine, sparingly soluble in tetrahydrofuran, and slightly soluble in methanol,
ethanol (99.5%), ethyl acetate, propan-2-ol and acetonitrile.
The inactive ingredients of IRESSA tablets are: Tablet core: Lactose
monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium
lauryl sulfate and magnesium stearate. Coating: Hypromellose, polyethylene
glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide.Last reviewed on RxList: 10/2/2008




Iressa Drug Description
IRESSA®
(gefitinib) Tablets, 250 mg
DRUG DESCRIPTION



What are the possible side effects of gefitinib (Iressa)?

If you experience any of the following serious side effects from gefitinib, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
eye pain or irritation.

Other, less serious...
Read All Potential Side Effects for Iressa »




IRESSA® (gefitinib tablets) contain 250 mg of gefitinib and
are available as brown film-coated tablets for daily oral administration.
Gefitinib is an anilinoquinazoline with the chemical name 4-Quinazolinamine,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin) propoxy] and
the following structural formula:








It has the molecular formula C22H24ClFN4O3,
a relative molecular mass of 446.9 and is a white-colored powder. Gefitinib
is a free base. The molecule has pKas of 5.4 and 7.2 and therefore
ionizes progressively in solution as the pH falls. Gefitinib can be defined
as sparingly soluble at pH 1, but is practically insoluble above pH 7, with
the solubility dropping sharply between pH 4 and pH 6. In non-aqueous solvents,
gefitinib is freely soluble in glacial acetic acid and dimethylsulphoxide, soluble
in pyridine, sparingly soluble in tetrahydrofuran, and slightly soluble in methanol,
ethanol (99.5%), ethyl acetate, propan-2-ol and acetonitrile.
The inactive ingredients of IRESSA tablets are: Tablet core: Lactose
monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium
lauryl sulfate and magnesium stearate. Coating: Hypromellose, polyethylene
glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide.Last reviewed on RxList: 10/2/2008




Iressa Drug Description
IRESSA®
(gefitinib) Tablets, 250 mg
DRUG DESCRIPTION



What are the possible side effects of gefitinib (Iressa)?

If you experience any of the following serious side effects from gefitinib, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
eye pain or irritation.

Other, less serious...
Read All Potential Side Effects for Iressa »




IRESSA® (gefitinib tablets) contain 250 mg of gefitinib and
are available as brown film-coated tablets for daily oral administration.
Gefitinib is an anilinoquinazoline with the chemical name 4-Quinazolinamine,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin) propoxy] and
the following structural formula:








It has the molecular formula C22H24ClFN4O3,
a relative molecular mass of 446.9 and is a white-colored powder. Gefitinib
is a free base. The molecule has pKas of 5.4 and 7.2 and therefore
ionizes progressively in solution as the pH falls. Gefitinib can be defined
as sparingly soluble at pH 1, but is practically insoluble above pH 7, with
the solubility dropping sharply between pH 4 and pH 6. In non-aqueous solvents,
gefitinib is freely soluble in glacial acetic acid and dimethylsulphoxide, soluble
in pyridine, sparingly soluble in tetrahydrofuran, and slightly soluble in methanol,
ethanol (99.5%), ethyl acetate, propan-2-ol and acetonitrile.
The inactive ingredients of IRESSA tablets are: Tablet core: Lactose
monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium
lauryl sulfate and magnesium stearate. Coating: Hypromellose, polyethylene
glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide.Last reviewed on RxList: 10/2/2008




Iressa Drug Description
IRESSA®
(gefitinib) Tablets, 250 mg
DRUG DESCRIPTION



What are the possible side effects of gefitinib (Iressa)?

If you experience any of the following serious side effects from gefitinib, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
eye pain or irritation.

Other, less serious...
Read All Potential Side Effects for Iressa »




IRESSA® (gefitinib tablets) contain 250 mg of gefitinib and
are available as brown film-coated tablets for daily oral administration.
Gefitinib is an anilinoquinazoline with the chemical name 4-Quinazolinamine,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin) propoxy] and
the following structural formula:








It has the molecular formula C22H24ClFN4O3,
a relative molecular mass of 446.9 and is a white-colored powder. Gefitinib
is a free base. The molecule has pKas of 5.4 and 7.2 and therefore
ionizes progressively in solution as the pH falls. Gefitinib can be defined
as sparingly soluble at pH 1, but is practically insoluble above pH 7, with
the solubility dropping sharply between pH 4 and pH 6. In non-aqueous solvents,
gefitinib is freely soluble in glacial acetic acid and dimethylsulphoxide, soluble
in pyridine, sparingly soluble in tetrahydrofuran, and slightly soluble in methanol,
ethanol (99.5%), ethyl acetate, propan-2-ol and acetonitrile.
The inactive ingredients of IRESSA tablets are: Tablet core: Lactose
monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium
lauryl sulfate and magnesium stearate. Coating: Hypromellose, polyethylene
glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide.Last reviewed on RxList: 10/2/2008




Iressa Drug Description
IRESSA®
(gefitinib) Tablets, 250 mg
DRUG DESCRIPTION



What are the possible side effects of gefitinib (Iressa)?

If you experience any of the following serious side effects from gefitinib, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
eye pain or irritation.

Other, less serious...
Read All Potential Side Effects for Iressa »




IRESSA® (gefitinib tablets) contain 250 mg of gefitinib and
are available as brown film-coated tablets for daily oral administration.
Gefitinib is an anilinoquinazoline with the chemical name 4-Quinazolinamine,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin) propoxy] and
the following structural formula:








It has the molecular formula C22H24ClFN4O3,
a relative molecular mass of 446.9 and is a white-colored powder. Gefitinib
is a free base. The molecule has pKas of 5.4 and 7.2 and therefore
ionizes progressively in solution as the pH falls. Gefitinib can be defined
as sparingly soluble at pH 1, but is practically insoluble above pH 7, with
the solubility dropping sharply between pH 4 and pH 6. In non-aqueous solvents,
gefitinib is freely soluble in glacial acetic acid and dimethylsulphoxide, soluble
in pyridine, sparingly soluble in tetrahydrofuran, and slightly soluble in methanol,
ethanol (99.5%), ethyl acetate, propan-2-ol and acetonitrile.
The inactive ingredients of IRESSA tablets are: Tablet core: Lactose
monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium
lauryl sulfate and magnesium stearate. Coating: Hypromellose, polyethylene
glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide.Last reviewed on RxList: 10/2/2008





Other reviews about Iressa on wordpress

Iressa ®
  by kinasepro
Iressa ®, gefitinib, ZD-1839 Discovery: Zeneca (UK) WO/1996/016960 US approval: May 2003 Label change: June 2005 FDA has approved new labeling for Iressa that states the medicine should be used only in […]


Peer-Review is Over-Rated
  by kinasepro
Putting a kinase domain on the cover is going to get a little attention, but putting this in the abstract is like sending an invitation to amateur hour: ...The […]


Health - Pill as good as chemo on lung cancer,but costlier
  by spoonfeedin
MARIA CHENGLONDON – Some advanced lung cancer patients already treated with chemotherapy might be able to skip some of the bad side effects of another series of chemo […]


Take a Pill, Skip Chemo
  by sunil khemaney
Study: Pill as good as chemo for some patients (CNN) -- A cancer treatment that comes in a pill is as effective as the standard chemotherapy for lung […]


Iressa as Good as Chemotherapy for Lung Cancer
  by timeinctemp
FRIDAY, Nov. 21 (HealthDay News) -- The cancer-fighting pill Iressa works as well as chemotherapy as a second-line treatment for lung cancer, researchers report. Although neither therapy prolongs survival […]


Health - Decoded: Expect early detection, better drugs for lung, skin cancer
  by spoonfeedin
LONDON: Scientists have identified all the changes in cells of two deadly cancers to produce the first entire cancer gene maps, calling the findings Twitter Facebook […]


Gefitinib Improves Progression-Free Survival in Metastatic Breast Cancer
  by wngai
According to a new study published in the Clinical Cancer Research, adding epidermal growth factor receptor (EGFR) inhibitor gefitinib (Iressa) to anastrozole (Arimidex) improved progression-free survival in postmenopausal […]


Tailored Treatment for Advanced Lung Cancer?
  by nalonsospc
By Alan MozesHealthDay Reporter WEDNESDAY, June 23 (HealthDay News) -- Advanced lung cancer is notoriously hard to treat, but a team of Japanese scientists reports that a cancer drug […]


Gefitinib (Iressa) is better than Standard Therapy in Lung Cancer with EGFR Mutations
  by wngai
Gefitinib (Iressa) is more effective than first-line therapy in improving survival without disease in patients with advanced nonsmall-cell lung cancer (NSCLC) and epidermal growth-factor receptor (EGFR) mutations.  The current […]


Advanced Cancer Of The Lungs In Some Patients Can Be Cured By The Drug Iressa
  by erickahleffert
Advanced Cancer Of The Lungs In Some Patients Can Be Cured By The Drug Iressa. Advanced lung cancer is notoriously oppressive to treat, but a party of Japanese […]



Other reviews about Iressa on web:

Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines ... IRESSA (gefitinib) | Non Small Cell Lung Cancer Treatment


IRESSA for advanced non-small cell lung cancer treatment with an EGFR-TK (epidermal growth factor receptor-tyrosine kinase) inhibitor. Site provides relevant lung cancer ... IRESSA Access


Gefitinib (pronounced /ɡɛˈfɪtɨnɪb/) (Iressa) is a drug used in the treatment of certain types of cancer. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts a ... Gefitinib - Wikipedia, the free encyclopedia


Learn about the prescription medication Iressa (Getfitinib), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Iressa (Getfitinib) Drug Information: Uses, Side Effects, Drug ...


Iressa (gefitinib) is used in the treatment of non-small cell lung cancer. Includes Iressa side effects, interactions and indications. Iressa Information from Drugs.com


Accurate, FDA approved Iressa information for healthcare professionals and patients - brought to you by Drugs.com. Iressa Official FDA information, side effects and uses.


IRESSA - treatment of advanced non-small cell lung cancer. IRESSA-us.com provides relevant disease information to health care professionals, patients, caregivers and journalists. IRESSA Access


Generic drug name: gefitinib. Brand/trade name: Iressa. Manufactured by: AstraZeneca. FDA approval: Approval in the United States is limited to patients who previously benefited in June ... Lung Cancer Alliance - Education - Emerging Treatments in Lung ...


Iressa (gefitinib) is usually administered to those patients who are suffering from non-small cell lung, which is a type of lung cancer. Before taking Iressa (gefitinib), your ... NorthWestPharmacy.com


Buy Iressa No Prescription, This week on Herding Code, Kevin leads a conversation with Javier Lozano on ASP.NET MVC and the Model View Controller (MVC), Model View Presenter ... Buy Lorazepam No Prescription | Herding Code





Featured Reviews

Reviews injection)

Physostigmine Salicylate Drug Description Physostigmine Salicylate Injection DRUG DESCRIPTION Physostigmine Salicylate Injection is a derivative of the Calabar bean, and its active moiety, physostigmine, is also known as eserine. Its...
Read More  |  Review This
Reviews Coagulation Factor IX Recombinant

Benefix Drug Description BeneFIX® [coagulation factor IX (recombinant)] DRUG DESCRIPTION What are the possible side effects of coagulation factor IX (Alphanine SD, Benefix, Mononine)? Get emergency medical help if you have...
Read More  |  Review This
Reviews Norethindrone Acetate and Ethinyl Estradiol

Estrostep 21 Drug Description ESTROSTEP® 21 (norethindrone acetate and ethinyl estradiol) Tablets, USP (Each white triangular tablet contains 1 mg norethindrone acetate and 20 mcg ethinyl estradiol; each white square tablet contains...
Read More  |  Review This
Reviews Doxycycline Hyclate

Atridox Drug Description ATRIDOX® (doxycycline hyclate) 10% DRUG DESCRIPTION What are the possible side effects of doxycycline? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty...
Read More  |  Review This
Reviews Tegretol

Tegretol Drug Description Tegretol® (carbamazepine) USP Chewable Tablets of 100 mg - red-speckled, pink Tablets of 200 mg - pink, Suspension of 100 mg/5 mL Tegretol®-XR (carbamazepine) Extended-release tablets 100 mg,...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....